V

VelosBio Inc.

27 employees

VelosBio is a next-generation oncology company, developing novel antibody-drug conjugates to treat haematological cancers.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Medical

Date founded

2017

Funding rounds raised

Total raised

$137M

from 15 investors over 15 rounds

V

VelosBio Inc. raised $137M on July 8, 2020

Investors: T. Rowe Price, Takeda UK Limited, Sofinnova Ventures, Russia technology fund, Pappas Capital, OrbiMed Advisors, Surveyor Capital, Viking Global Investors, Venrock and Wellington Management

V

VelosBio Inc. raised $58M on October 1, 2018

Investors: Chiesi Ventures, Arix Bioscience plc, Pappas Ventures, Sofinnova Ventures, Russia technology fund, Decheng Capital and Takeda UK Limited

FAQ